Study of ALN's OATF Vena Cava Filter
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Filter implantation
研究概览
简要总结
Migration of a thrombus in the pulmonary circulation is the leading cause of pulmonary embolism (PE). It can be prevented mechanically by implanting a vena cava filter (VCF) in the inferior vena cava. The implation of a VCF is indicated for patients with acute PE and a contraindication to anticoagulation, with an acute deep vein thrombosis (DVT) without PE and a contraindication to anticoagulation or with acute venous thromboembolism (less than 3 months) in whom an interventional gesture at hemorrhagic and thromboembolic risk contraindicates anticoagulation.
The purpose of this study is to describe the rates of implantation, removal and complications associated with the use of the optional ALN OATF VCF in current practice.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient implanted with an ALN OATF VCF
- •Patient informed
排除标准
- •Minor patient
- •Adult patient under a legal protection measure
- •Pregnant, parturient or breastfeeding women
- •Patient who refused to participate
- •Patient who cannot or does not wish to be followed by the Interventional Radiology Department
研究组 & 干预措施
Vena Cava Filter
Participants implanted with the vena cava filter OATF (ALN)
干预措施: Filter implantation (Device)
结局指标
主要结局
Filter implantation
时间窗: day 0
Rate of technical success of filter implantation
次要结局
- Filter removal(up to 1 year)